A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED TYPE-2 DIABETIC-PATIENTS

Authors
TRONIER B MARBURY TC DAMSBO P WINDFELD K
Citation
B. Tronier et al., A NEW ORAL HYPOGLYCEMIC AGENT, REPAGLINIDE MINIMIZES RISK OF HYPOGLYCEMIA IN WELL-CONTROLLED TYPE-2 DIABETIC-PATIENTS, Diabetes, 44, 1995, pp. 70-70
Citations number
NO
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Journal title
Diabetes → ACNP
ISSN journal
00121797
Volume
44
Year of publication
1995
Supplement
1
Pages
70 - 70
Database
ISI
SICI code
0012-1797(1995)44:<70:ANOHAR>2.0.ZU;2-B